Free Trial

Edwards Lifesciences (EW) Competitors

Edwards Lifesciences logo
$74.81 +0.88 (+1.19%)
(As of 12/20/2024 05:31 PM ET)

EW vs. SYK, BSX, MDT, BDX, IDXX, RMD, DXCM, STE, PODD, and HOLX

Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Hologic (HOLX). These companies are all part of the "health care equipment" industry.

Edwards Lifesciences vs.

Stryker (NYSE:SYK) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Stryker presently has a consensus price target of $405.80, suggesting a potential upside of 11.78%. Edwards Lifesciences has a consensus price target of $79.40, suggesting a potential upside of 6.62%. Given Stryker's stronger consensus rating and higher probable upside, analysts plainly believe Stryker is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stryker
0 Sell rating(s)
3 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.85
Edwards Lifesciences
0 Sell rating(s)
15 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.42

Stryker has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stryker$21.97B6.30$3.17B$9.3338.91
Edwards Lifesciences$6.31B6.96$1.40B$6.9310.75

In the previous week, Edwards Lifesciences had 13 more articles in the media than Stryker. MarketBeat recorded 26 mentions for Edwards Lifesciences and 13 mentions for Stryker. Stryker's average media sentiment score of 1.04 beat Edwards Lifesciences' score of 0.52 indicating that Stryker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stryker
6 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
10 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Edwards Lifesciences has a net margin of 70.82% compared to Stryker's net margin of 16.34%. Stryker's return on equity of 23.07% beat Edwards Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Stryker16.34% 23.07% 11.04%
Edwards Lifesciences 70.82%20.76%15.27%

Edwards Lifesciences received 411 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 71.03% of users gave Edwards Lifesciences an outperform vote while only 64.77% of users gave Stryker an outperform vote.

CompanyUnderperformOutperform
StrykerOutperform Votes
923
64.77%
Underperform Votes
502
35.23%
Edwards LifesciencesOutperform Votes
1334
71.03%
Underperform Votes
544
28.97%

Stryker has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

77.1% of Stryker shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 5.9% of Stryker shares are held by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Stryker beats Edwards Lifesciences on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EW vs. The Competition

MetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$43.92B$9.56B$5.02B$19.25B
Dividend YieldN/A1.35%4.87%3.55%
P/E Ratio10.7519.66135.5841.35
Price / Sales6.9631.971,118.2617.48
Price / Cash26.7122.3940.6621.28
Price / Book6.725.514.775.34
Net Income$1.40B$182.72M$118.58M$988.53M
7 Day Performance1.57%-3.80%-1.65%-3.15%
1 Month Performance7.09%-1.33%12.46%-2.01%
1 Year Performance0.47%-10.85%31.93%14.41%

Edwards Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
3.918 of 5 stars
$74.81
+1.2%
$79.40
+6.1%
+0.9%$44.12B$6.31B10.8019,800High Trading Volume
SYK
Stryker
4.9648 of 5 stars
$374.74
+0.0%
$404.35
+7.9%
+26.5%$142.86B$21.97B40.1852,000Analyst Forecast
BSX
Boston Scientific
4.3943 of 5 stars
$91.10
+1.1%
$95.52
+4.9%
+61.8%$134.27B$15.91B75.0248,000Analyst Forecast
MDT
Medtronic
4.9289 of 5 stars
$81.91
-0.7%
$95.27
+16.3%
+0.5%$105.03B$33.00B25.1495,000Analyst Forecast
Options Volume
BDX
Becton, Dickinson and Company
4.9003 of 5 stars
$231.06
+2.4%
$283.50
+22.7%
-5.1%$66.80B$20.18B37.9774,000Analyst Downgrade
Insider Trade
Analyst Revision
IDXX
IDEXX Laboratories
4.9773 of 5 stars
$433.24
+0.3%
$539.63
+24.6%
-23.6%$35.48B$3.84B41.6711,000
RMD
ResMed
4.5175 of 5 stars
$240.78
+0.9%
$227.91
-5.3%
+36.4%$35.35B$4.81B31.599,980Positive News
DXCM
DexCom
4.9076 of 5 stars
$76.34
-1.1%
$98.00
+28.4%
-31.4%$29.82B$3.95B46.229,600
STE
STERIS
4.9332 of 5 stars
$213.81
-0.2%
$262.50
+22.8%
-3.5%$21.11B$5.14B48.9118,179Positive News
PODD
Insulet
4.2395 of 5 stars
$265.70
-1.4%
$267.44
+0.7%
+28.2%$18.64B$1.70B46.123,000Positive News
HOLX
Hologic
4.7066 of 5 stars
$73.06
-0.8%
$89.50
+22.5%
+1.9%$16.58B$4.03B22.147,063Analyst Forecast

Related Companies and Tools


This page (NYSE:EW) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners